1. Medtech Insight
  2. >>Business
  3. >>R&D

Gore Unleashes Tigris Peripheral Stent In The US

 
• By Reed Miller

The company says the device's flexibility and durability give it critical advantages over other stents in difficult-to-treat peripheral arteries.

Tigris
Gore's Tigris stent for the superficial femoral or proximal popliteal arteries • Source: WL Gore

WL Gore & Associates Inc. expects US FDA approval of its Tigris heparin-coated peripheral vascular stent, announced Aug. 2, to expand the peripheral artery disease patient population that can be safely treated with vascular stents.

According to Gore, there are between 8 million and 12 million peripheral artery disease patients in the US. Treating diseased...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from R&D

More from Business

J&J MedTech Launches KINCISE 2 Surgical Automated System In US

 
• By Natasha Barrow

The KINCISE 2 Surgical Automated System aims to “reduce the physical burden on surgeons compared to manual impaction in primary and revision hip and revision knee replacement procedures,” said J&J MedTech.

Quest Diagnostics Minimizes China Tariff Risk With Less Than 1% Supply Chain Exposure

 
• By Shubham Singh

Quest reaffirmed its full-year guidance despite macroeconomic concerns and tariff uncertainty. Revenues are expected between $10.7bn and $10.85bn. Adjusted earnings per share (EPS) is estimated in the $9.55 to $9.80 range for the full year, with EPS between $8.62 and $8.87.

Abbott Launches Next-Gen Delivery System For Proclaim DRG Neurostim

 
• By Shubham Singh

Allen Burton, Abbott’s medical director of neuromodulation told Medtech Insight that the delivery system was developed to make the procedure easier for physicians, especially those who perform the implantations infrequently.